top of page
A Phase 1 Dose Escalation Study to Investigate Safety, Tolerability, and Pharmacokinetics of ANAVEX 2-73 in Healthy Male Subjects.
CNS Summit 2014, Boca Raton, FL
Ole Voges, Ingo Weigmann, Norman Bitterlich, Christoph Schindler and Christopher Missling
1/0
bottom of page